|
|
||||||||
1 Division of Pulmonary/Critical Care Medicine, Stanford University Medical Center, Stanford, California 94305-5236
3 Department of Anesthesiology, Stanford University Medical Center, Stanford, California 94305-5236
2 Department of Biostatistics, University of Washington, Seattle, Washington 98195-7232
Pneumonectomized rats injected with the alkaloid toxin, monocrotaline, develop progressive neointimal pulmonary vascular obliteration and pulmonary hypertension resulting in right ventricular failure and death. The antiproliferative immunosuppressant, triptolide, attenuates neointimal formation and pulmonary hypertension in this disease model (Faul JL, Nishimura T, Berry GJ, Benson GV, Pearl RG, and Kao PN. Am J Respir Crit Care Med 162: 22522258, 2000). Pneumonectomized rats, injected with monocrotaline on day 7, were killed at days 14, 21, 28, and 35 for measurements of physiology and gene expression patterns. These data were compared with pneumonectomized, monocrotaline-injected animals that received triptolide from day 5 to day 35. The hypothesis was tested that a group of functionally related genes would be significantly coexpressed during the development of disease and downregulated in response to treatment. Transcriptional analysis using total lung RNA was performed on replicate animals for each experimental time point with exploratory data analysis followed by statistical significance analysis. Marked, statistically significant increases in proteases (particularly derived from mast cells) were noted that parallel the development of vascular obliteration and pulmonary hypertension. Mast-cell-derived proteases may play a role in regulating the development of neointimal pulmonary vascular occlusion and pulmonary hypertension in response to injury.
proteinases; gene expression analysis; mast cells; monocrotaline
This article has been cited by other articles:
![]() |
N. R. Bauer, T. M. Moore, and I. F. McMurtry Rodent models of PAH: are we there yet? Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L580 - L582. [Full Text] [PDF] |
||||
![]() |
A. M. Assaad, S. M. Kawut, S. M. Arcasoy, E. B. Rosenzweig, J. S. Wilt, J. R. Sonett, and A. C. Borczuk Platelet-Derived Growth Factor Is Increased in Pulmonary Capillary Hemangiomatosis Chest, March 1, 2007; 131(3): 850 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liang and B. Ventura Physiological genomics in PG and beyond: October to December 2005 Physiol Genomics, December 14, 2005; 24(1): 1 - 3. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |